Clinical Trials Directory

Trials / Completed

CompletedNCT02537301

Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by a Group of Doctors

Endoscopic Retrograde Cholangiopancreatography(ERCP)-Related Discussion Through a Mobile Social App by Trainees After Finishing ERCP Training

Status
Completed
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Air Force Military Medical University, China · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Group chat through the platform of mobile social networking provides an easily accessible, real-time and interactive channel for communication. With the help of mobile social app, a group of doctors with similar interests can share valuable cases, important papers and opinions through multiple media types (texts, images, and videos). It remains unknown what activities of Endoscopic Retrograde Cholangiopancreatography(ERCP) doctors on a group-chat platform are. In the beginning of 2013, a chatting group on Wechat (the most popular mobile social app in China), focusing on ERCP, was created. All the doctors who received and finished their ERCP training in Xijing Hospital of Digestive Diseases were invited to join in the platform. The contents in the chatting group were analyzed. The relationships between the chatting activities of ERCP doctors and the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) were investigated.

Conditions

Interventions

TypeNameDescription
OTHERjoining in the platformThe activities (contents, chatting frequency etc.) of ERCP doctors on the chatting group were retrospectively extracted. The data related to the performance of ERCP (such as case volume, cannulation success rate and PEP etc.) by ERCP doctors were collected by a questionaire.

Timeline

Start date
2015-06-01
Primary completion
2016-01-01
Completion
2016-01-01
First posted
2015-09-01
Last updated
2016-01-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02537301. Inclusion in this directory is not an endorsement.